Moderna vaccine trial pleases investors, EBIT...

Up next

Martin Wolf on the US midterms: What’s the risk of political violence?

As Americans prepare to vote in the November 3 midterm elections, the FT’s chief economics commentator Martin Wolf asks what the result will mean for Donald Trump, the future of US democracy and America's place in the world. In the third of a six-part series, Martin speaks to pol ... Show more

. 36min 54sec

Alphabet’s brutal day on the stock market

Alphabet’s share price fell just over 12 percent on Thursday, and UK startup Nscale is banking on a troubled US data centre project to underpin its planned $35bn IPO. Plus, we look at what’s next for the ECB now that its president Christine Lagarde announced she’s stepping down.M ... Show more

. 12min 15sec

Recommended Episodes

Hello From the Other Side? And Bitcoin Puts in Another Big Week

CNBC's "Fast Money"

There’s more positive news on the vaccine front, companies are raising dividends, and earnings guidance has been strong. Corporate America seems to think we’ve gotten past the worst effects of the pandemic, but have we?

Plus Bitcoin nearing the $19,000 mark after surging ...

. 22min 0sec

Understanding Evergrande, Dell’s Post-Spinoff Outlook & Flying Cars

Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster s ... Show more

. 44min 6sec

Stocks Surge, Moderna Skyrockets, Goldman’s Blowout Quarter, Needham Ups Apple

Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discuss the surge in stocks. Markets getting a boost from blowout results from Goldman Sachs and Moderna’s vaccine news. Goldman Sachs crushing earnings estimates its biggest outperformance in nearly a decade. Revenue was more than ...

. 44min 36sec